NCT03819296 2026-03-11Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerM.D. Anderson Cancer CenterPhase 1 Recruiting800 enrolled
NCT01310803 2017-10-05Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the BladderEndo PharmaceuticalsPhase 3 Terminated1 enrolled 5 charts